There are changes and clarifications to definitions that are needed in the 340B program, but that won't likely happen anytime soon in this Congress. In the meantime, various stakeholders should take the time to educate one another on what the program means to them, said Neil Minkoff, MD, chief medical officer of EmpiraMed.
There are changes and clarifications to definitions that are needed in the 340B program, but that won't likely happen anytime soon in this Congress. In the meantime, various stakeholders should take the time to educate one another on what the program means to them, said Neil Minkoff, MD, chief medical officer of EmpiraMed.
Transcript
What future changes do you expect to see for the 340B program?
In the next 18 months? Very little, if any. I mean I think that Congress is so overwhelmed right now with the Affordable Care Act, the American Health Care Act (AHCA), what's going to replace the AHCA that a prorgam like this is kind of being pushed aside. Now there was supposed to be new rules for 340B in Q1 of 2017, but as part of the new administration trying to reduce the number of rules and regulations that change is on hold. So HHS will eventually get back to it, but God only knows when that's going to happen to provide some of those clearer definitions.
Also, if Congress acts to change the way people are getting paid in healthcare or to make significant changes to the ACA, changing that and 340B pricing at the same time might just be too much. I might have to be more of a phased approach.
How does the 340B program mean different things to different stakeholders?
I think that 340B pricing is one of those situations where the different stakeholders really need to start educating each other. So the hospitals need to make it clear to the payers what the benefit is to the hospital and their patients and indigent care, and so on. The payers need to have a clearer understanding with their pharmacies and the manufacturers of how it affects them. And the manufacturers need to educate the payers about the potential for double discount and what is means to them.
So I think we're at a point now where the plans are kind of waking up to 340B, which has been a big reality for the providers and for the manufacturers for a long time. And so we're still in a period of a lot of education.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More